Plan to Fight Zika with GM Mosquitoes in Florida Faces Opposition

Officials postpone the launch of an experimental program aimed at reducing local mosquito populations with genetically modified insects.

Written byBen Andrew Henry
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

JEFF MILLER

Earlier this month (August 5), the US Food and Drug Administration (FDA) OKed a plan to help slow the spread of Zika virus in the Florida Keys using genetically modified (GM) mosquitoes, having found no evidence of danger to the environment or people. But Mila de Mier, a local real estate agent and vocal critic of the plan, isn’t buying it. “Opening this Pandora’s box, sometimes you don’t see the impact until five, 10, 15 years down the road,” she told The Guardian. De Mier started an online petition against the use of GM mosquitoes that to date has collected nearly 170,000 signatures.

In response to public opposition, the local mosquito control board has delayed the launch of the experimental program and will allow residents ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform